These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17915430)

  • 1. [Oral treatment of type 2 diabetes mellitus].
    Olsovský J
    Vnitr Lek; 2007; 53(7-8):853-4, 856-8. PubMed ID: 17915430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Good practice and update in oral antidiabetic agents].
    Vandemergel X
    Rev Med Brux; 2010 Sep; 31(4):371-6. PubMed ID: 21089417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
    Koski RR
    Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New oral antidiabetic agents and current strategies of peroral antidiabetic therapy (PAD)].
    Rybka J; Kvapil M
    Vnitr Lek; 2002 Jun; 48(6):517-22. PubMed ID: 12132353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes mellitus and Aboriginal Australians. Options for oral therapy in the control of glyceamia.
    Bell D
    Aust Fam Physician; 1998 Nov; 27(11):1017-20. PubMed ID: 9845993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current cost analysis in the management of diabetes mellitus].
    Oberender P
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S110-4; discussion S124-6. PubMed ID: 18686219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of type 2 diabetes mellitus with oral antihyperglycaemic therapy.
    Desai A; Tandon N
    Natl Med J India; 2007; 20(4):192-8. PubMed ID: 18085125
    [No Abstract]   [Full Text] [Related]  

  • 9. [New oral antidiabetic glitazones].
    Johansen K
    Ugeskr Laeger; 2001 Dec; 164(1):76-7. PubMed ID: 11810811
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining insulin therapy in type 2 diabetes mellitus.
    Rosenstock J
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):21-9. PubMed ID: 19667676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S; Alvarsson M; Brismar K; Wagner H
    Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: treating type 2 diabetes. Using four oral hypoglycemic drugs.
    Lockman LE
    Can Fam Physician; 2003 Jun; 49():775-6. PubMed ID: 12836866
    [No Abstract]   [Full Text] [Related]  

  • 15. New antidiabetic medications. Clinical evidence, clinical practice and pharmacoeconomics.
    Graham-Clarke P; Mullen K
    Aust Fam Physician; 2001 Dec; 30(12):1145-8. PubMed ID: 11838393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral treatment of diabetes mellitus type 2. Limitations, perspectives].
    Dumitrescu C; Găvănescu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(1):71-7. PubMed ID: 2873647
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].
    Gale EA
    Ugeskr Laeger; 2001 Dec; 163(50):7032-5. PubMed ID: 11794032
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
    Yang WY; Ji QH; Zhu DL; Yang JK; Chen LL; Liu ZM; Yu DM; Yan L
    Chin Med J (Engl); 2009 Jul; 122(14):1704-8. PubMed ID: 19719975
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA; Kulkarni KD
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.